RxDoctor Payments Data

Jesse Mez, MD

Neurology · Boston, MANPI 1629112073

Payments from drug & device makers

$393,853in general payments, 2019–2025

Across 32 payments — averaging $12,308 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$394K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eisai Inc.32$393,853

How this compares

$393,853 in reported general payments places this provider in the 90th percentile of 761 neurology providers in Massachusetts.

See all neurology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$6,567
Medicare patients
16
Services billed
44

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Memantine Hcl18$2,278
Galantamine Hbr13$1,251
Donepezil Hcl28$220
Sertraline Hcl17$57
Fluoxetine Hcl11$38

Paid to pharmacies, not to this prescriber.

Other neurology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →